Bayer petitions U.S. Supreme Court to review Roundup case
Bayer (OTCPK:BAYZF) (OTCPK:BAYRY), through its subsidiary Monsanto, on Friday filed a petition with the U.S. Supreme Court ...
Bayer Asks Supreme Court to Review Roundup Case
In 2023, a Missouri Circuit Court returned a verdict in favor of John Durnell, who alleged the weed control product Roundup caused non-Hodgkin's lymphoma. Bayer bought the agrochemical company ...
Experts Challenge New Aspirin Guidelines
Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease. The American Heart ...
Study Finds4d
The Great Aspirin Debate: Why Age-Based Guidelines Are Being Questioned
Researchers from Florida Atlantic University argue that doctors should consider each patient's individual risk profile rather ...
Experts challenge aspirin guidelines based on their undue reliance on a flawed trial
Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease. The American Heart ...
New Scientist5d
Does aspirin have potential as an anti-cancer drug?
Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...
Bayer eyes launch of menopause relief, heart drugs this year
Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of at least $1 billion, as it seeks to strengthen its pharmaceuticals business ...